Fragment Screening by Weak Affinity Chromatography: Comparison with Established Techniques for Screening against HSP90

被引:43
|
作者
Meiby, Elinor [1 ]
Simmonite, Heather [2 ]
le Strat, Loic [2 ]
Davis, Ben [2 ]
Matassova, Natalia [2 ]
Moore, Jonathan D. [2 ]
Mrosek, Michael [2 ]
Murray, James [2 ]
Hubbard, Roderick E. [2 ,3 ]
Ohlson, Sten [1 ,4 ]
机构
[1] Linnaeus Univ, Dept Chem & Biomed Sci, SE-39182 Kalmar, Sweden
[2] Vernalis, Cambridge CB21 6GB, England
[3] Univ York, YSBL, York YO10 5DD, N Yorkshire, England
[4] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore
关键词
INHIBITORS; DISCOVERY; LIGAND; BINDING; IDENTIFICATION; PROTEINS; DESIGN;
D O I
10.1021/ac400715t
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The increasing use of fragment-based lead discovery (FBLD) in industry as well as in academia creates a high demand for sensitive and reliable methods to detect the binding of fragments to act as starting points in drug discovery programs. Nuclear magnetic resonance (NMR), surface plasmon resonance (SPR), and X-ray crystallography are well-established methods for fragment finding, and thermal shift and fluorescence polarization (FP) assays are used to a lesser extent. Weak affinity chromatography (WAC) was recently introduced as a new technology for fragment screening. The study presented here compares screening of 111 fragments against the ATPase domain of HSP90 by all of these methods, with isothermal titration calorimetry (ITC) used to confirm the most potent hits. The study demonstrates that WAC is comparable to the established methods of ligand-based NMR and SPR as a hit-id method, with hit correlations of 88% and 83%, respectively. The stability of HSP90 WAC columns was also evaluated and found to give 90% reproducibility even after 207 days of storage. A good correlation was obtained between the various technologies, validating WAC as an effective technology for fragment screening.
引用
收藏
页码:6756 / 6766
页数:11
相关论文
共 50 条
  • [21] A novel class of Hsp90 inhibitors isolated by structure-based virtual screening
    Park, Hwangseo
    Kim, Yun-Jung
    Hahn, Ji-Sook
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (22) : 6345 - 6349
  • [22] High-throughput screening fluorescence polarization assay for tumor-specific Hsp90
    Du, Yuhong
    Moulick, Kamalika
    Rodina, Anna
    Aguirre, Julia
    Felts, Sara
    Dingledine, Raymond
    Fu, Haian
    Chiosis, Gabriela
    JOURNAL OF BIOMOLECULAR SCREENING, 2007, 12 (07) : 915 - 924
  • [23] Transcriptomics-Based Screening Identifies Pharmacological Inhibition of Hsp90 as a Means to Defer Aging
    Janssens, Georges E.
    Lin, Xin-Xuan
    Millan-Arino, Lluis
    Kavsek, Alan
    Sen, Ilke
    Seinstra, Renee, I
    Stroustrup, Nicholas
    Nollen, Ellen A. A.
    Riedel, Christian G.
    CELL REPORTS, 2019, 27 (02): : 467 - +
  • [24] Development of a Cell-Based Ligand-Screening System for Identifying Hsp90 Inhibitors
    Ueda, Tsuyoshi
    Tamura, Tomonori
    Hamachi, Itaru
    BIOCHEMISTRY, 2020, 59 (02) : 179 - 182
  • [25] The NHS Health Check programme: a comparison against established standards for screening
    Dalton, Andrew R. H.
    Marshall, Tom
    McManus, Richard J.
    BRITISH JOURNAL OF GENERAL PRACTICE, 2014, 64 (627): : 530 - 531
  • [26] NMR methods in fragment screening: theory and a comparison with other biophysical techniques
    Dalvit, Claudio
    DRUG DISCOVERY TODAY, 2009, 14 (21-22) : 1051 - 1057
  • [27] Discovery and Bioevaluation of Novel Pyrazolopyrimidine Analogs as Competitive Hsp90 Inhibitors Through ShapeBased Similarity Screening
    Xu, Xiao-Li
    Sun, Hao-Peng
    Liu, Fang
    Jia, Jian-Min
    Guo, Xiao-Ke
    Pan, Yang
    Huang, Hao-Ze
    Zhang, Xiao-Jin
    You, Qi-Dong
    MOLECULAR INFORMATICS, 2014, 33 (04) : 293 - 306
  • [28] Development of a FRET-based High-Throughput Screening System for the Discovery of Hsp90 Inhibitors
    Oh, Sangmi
    Ko, Yeonjin
    Lee, Hanjae
    Kim, Jonghoon
    Chung, Young Sun
    Park, Seung Bum
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2011, 32 (09) : 3229 - 3232
  • [29] DEVELOPMENT OF A HIGH-THROUGHPUT SCREENING ASSAY FOR THE IDENTIFICATION OF CANCER CELL-SPECIFIC HSP90
    Woodruff, Daniel
    Sadikot, Takrima
    Eskew, Jeff
    Blagg, Brian
    Vielhauer, George
    Holzbeierlein, Jeffrey
    JOURNAL OF UROLOGY, 2012, 187 (04): : E199 - E199
  • [30] Small Molecule Screening Identifies HSP90 as a Modifier of RNA Foci in Myotonic Dystrophy Type 1
    Johnson, Sara J.
    Johnson, Hannah L.
    Powell, Reid T.
    Stephan, Clifford
    Stossi, Fabio
    Cooper, Thomas A.
    MOLECULAR AND CELLULAR BIOLOGY, 2024,